<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sergey</forename><surname>Nikitenko</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Biophysical Chemistry</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Althanstr. 14</addrLine>
									<postCode>A-1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Annette</forename><surname>Rompel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Biophysical Chemistry</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Althanstr. 14</addrLine>
									<postCode>A-1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alfred</forename><surname>Hummer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Biophysical Chemistry</orgName>
								<orgName type="institution">University of Vienna</orgName>
								<address>
									<addrLine>Althanstr. 14</addrLine>
									<postCode>A-1090</postCode>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">A6446E91EF1A1DD17B0F6091EB77CB98</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T21:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>XAS study of Ru anticancer drugs in tumor tissues</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>Aims of the experiment and scientific background In the last two decades Ru anti cancer drugs were in the focus of scientists as possible alternatives for treatment of cancer types where Pt or other therapies failed. Three compounds turned out to be very promising (KP1019 = indazolium-trans-[tetrachlorobis(indazole)ruthenate(III)], KP1339 1 and NAMI-A 2 ). KP1019 was already studied in a clinical phase I trial. An activation by reduction from Ru(III) to Ru(II) is supposed <ref type="bibr" target="#b2">3</ref> . In contrast to Pt drugs which mainly cause cell death through DNA binding and distortion, the Ru mode involves other cell targets. Recent studies have shown strong interaction of Ru with cell proteins/membranes of differing size. The Ru transport and activation is strongly connected to the low molecular weight fraction (LMW) and cytotoxic activity to interactions with the high molecular weight (HMW) fraction. In the LMW fraction the proteins albumin and transferrin (Tf) and the tripeptide glutathione (GSH) are of interest. The HMW fraction mainly consists of Ru bound to cell membranes or ribosomes <ref type="bibr" target="#b3">4</ref> . It is supposed that albumin accomplishes the transport to the tumor tissue, Tf enhances the transport into the cell and GSH activates Ru(III) by reduction to Ru(II). But in the case of high GSH to Ru-drug ratio (10:1) a reduced Ru anti-cancer activity could be observed. This might be due to the fact of complexation of GSH to Ru <ref type="bibr" target="#b4">5</ref> . KP1019 and KP1339 are analogous salts only different in their cation, indazolium + for the former and Na + for the latter, making KP1339 more soluble in physiological buffer. The mode of action is supposed to be the same for both <ref type="bibr" target="#b5">6</ref> . Additionally both drugs possess the same first coordination sphere of RuCl 2 N 4 , which is of primary interest in XANES and EXAFS studies.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>EXAFS spectra were collected at the Ru K-edge for all models in duplicates to ensure reproducibility. Samples, enclosed in holders with kapton windows were kept frozen at all times. Cryogenic temperatures (about 15 K) ensure preservation of the samples. Data for biological samples were collected over a period of 12 h. In Fig. <ref type="figure" target="#fig_0">1</ref> (a) the XANES spectra of the model compounds are shown. The spectra are divided into three groups: (a) the Ru(II) model and (b) the Ru(III) compounds with sulfur ligands (c) the Ru(III) models with more electronegative ligands shifted to higher energies. The Ru-drug KP1019 falls in between. According to the Allred-Rochow scale the electronegativity of the ligands is S &lt; Cl &lt; N &lt; O with values of 2.4 &lt; 2.8 &lt; 3.1 &lt; 3.8, respectively. The coordination charge η of the compounds was calculated as described in formulas in <ref type="bibr" target="#b6">7</ref> and plotted versus the edge shift in comparison to KP1019 (set as arbitrary zero point). The edge position was determined according to the previously described integration method <ref type="bibr" target="#b7">8</ref> . Results obtained with the half-height method gave similar results (data not shown). In Fig. <ref type="figure">2</ref> (a) the XANES spectra of tumor and liver tissue in comparison to KP1019 dissolved in buffer solution are shown. The coordination of KP1019 in the two tissue samples seems to be the same but different from the pure Ru-drug. The two KP1019 spectra show similar edge features. The edge shift of the biological samples and KP1019 in buffer in comparison to KP1019 as a solid is shown in Fig. <ref type="figure">2 (b</ref>). </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 :</head><label>1</label><figDesc>XANES spectra of model compounds (a) and coordination charge versus edge shift in comparison to KP1019 (b), coordination charge η AR and η P according to Allred-Rochow and Pauling -scale (a) (b) Fig. 2: XANES spectra of KP1019 as a solid and dissolved in buffer (a) and edge shift of KP1019 in buffer and of the tumor/liver samples in comparison to KP1019 (Cl 4 N 2 ) as a solid (b)</figDesc></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)</title>
		<author>
			<persName><forename type="first">Christian</forename><forename type="middle">G</forename><surname>Hartinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Stefanie</forename><surname>Zorbas-Seifried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Jakupec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernd</forename><surname>Kynast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Haralabos</forename><surname>Zorbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jinorgbio.2006.02.013</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Inorganic Biochemistry</title>
		<title level="j" type="abbrev">Journal of Inorganic Biochemistry</title>
		<idno type="ISSN">0162-0134</idno>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">5-6</biblScope>
			<biblScope unit="page" from="891" to="904" />
			<date type="published" when="2006-05">2006</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Hartinger, C. G.; Zorbas-Seifried, S.; Jakupec, M. A.; Kynast, B.; Zorbas, H.; Keppler, B. K. Journal of Inorganic Biochemistry 2006, 100, 891-904.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Water‐Soluble Ruthenium(III)‐Dimethyl Sulfoxide Complexes:Chemical Behaviour and Pharmaceutical Properties</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mestroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Alessio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pacor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Coluccia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boccarelli</surname></persName>
		</author>
		<idno type="DOI">10.1155/mbd.1994.41</idno>
	</analytic>
	<monogr>
		<title level="j">Metal-Based Drugs</title>
		<title level="j" type="abbrev">Metal-Based Drugs</title>
		<idno type="ISSN">0793-0291</idno>
		<idno type="ISSNe">1687-5486</idno>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="41" to="63" />
			<date type="published" when="1994">1994</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Mestroni, G.; Alessio, E.; Sava, G.; Pacor, S.; Coluccia, M.; Boccarelli, A. Metal-Based Drugs 1994, 1, 41-63.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients</title>
		<author>
			<persName><forename type="first">Christian</forename><forename type="middle">G</forename><surname>Hartinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Jakupec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Stefanie</forename><surname>Zorbas‐seifried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><surname>Groessl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alexander</forename><surname>Egger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Walter</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Haralabos</forename><surname>Zorbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Paul</forename><forename type="middle">J</forename><surname>Dyson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<idno type="DOI">10.1002/cbdv.200890195</idno>
	</analytic>
	<monogr>
		<title level="j">Chemistry &amp; Biodiversity</title>
		<title level="j" type="abbrev">Chemistry &amp; Biodiversity</title>
		<idno type="ISSN">1612-1872</idno>
		<idno type="ISSNe">1612-1880</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2140" to="2155" />
			<date type="published" when="2008-10">2008</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Hartinger, C. G.; Jakupec, M. A.; Zorbas-Seifried, S.; Groessl, M.; Egger, A.; Berger, W.; Zorbas, H.; Dyson, P. J.; Keppler, B. K. Chemistry and Biodiversity 2008, 5, 2140-2155.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339</title>
		<author>
			<persName><forename type="first">Petra</forename><surname>Heffeter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Katharina</forename><surname>Böck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bihter</forename><surname>Atil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mir</forename><forename type="middle">Ali</forename><surname>Reza Hoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wilfried</forename><surname>Körner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Caroline</forename><surname>Bartel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ute</forename><surname>Jungwirth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michael</forename><surname>Micksche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Walter</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gunda</forename><surname>Koellensperger</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00775-010-0642-1</idno>
	</analytic>
	<monogr>
		<title level="j">JBIC Journal of Biological Inorganic Chemistry</title>
		<title level="j" type="abbrev">J Biol Inorg Chem</title>
		<idno type="ISSN">0949-8257</idno>
		<idno type="ISSNe">1432-1327</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="737" to="748" />
			<date type="published" when="2010-03-11">2010</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Heffeter, P.; Böck, K.; Atil, B.; Reza Hoda, M.; Körner, W.; Bartel, C.; Jungwirth, U.; Keppler, B.; Micksche, M.; Berger, W.; Koellensperger, G. Journal of Biological Inorganic Chemistry 2010, 15, 737-748.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Alterations in the Binding of [Cl(NH&lt;sub&gt;3&lt;/sub&gt;)&lt;sub&gt;5&lt;/sub&gt;Ru&lt;sup&gt;III&lt;/sup&gt;]&lt;sup&gt;2+&lt;/sup&gt; to DNA by Glutathione: Reduction, Autoxidation, Coordination, and Decomposition</title>
		<author>
			<persName><forename type="first">Dominic</forename><forename type="middle">R</forename><surname>Frasca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Clarke</surname></persName>
		</author>
		<idno type="DOI">10.1021/ja991113p</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Chemical Society</title>
		<title level="j" type="abbrev">J. Am. Chem. Soc.</title>
		<idno type="ISSN">0002-7863</idno>
		<idno type="ISSNe">1520-5126</idno>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">37</biblScope>
			<biblScope unit="page" from="8523" to="8532" />
			<date type="published" when="1999-09-01">1999</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Frasca, D. R.; Clarke, M. J. Journal of the American Chemical Society 1999, 121, 8523-8532.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Antitumour metal compounds: more than theme and variations</title>
		<author>
			<persName><forename type="first">Michael</forename><forename type="middle">A</forename><surname>Jakupec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mathea</forename><forename type="middle">S</forename><surname>Galanski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vladimir</forename><forename type="middle">B</forename><surname>Arion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><forename type="middle">G</forename><surname>Hartinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bernhard</forename><forename type="middle">K</forename><surname>Keppler</surname></persName>
		</author>
		<idno type="DOI">10.1039/b712656p</idno>
	</analytic>
	<monogr>
		<title level="j">Dalton Transactions</title>
		<title level="j" type="abbrev">Dalton Trans.</title>
		<idno type="ISSN">1477-9226</idno>
		<idno type="ISSNe">1477-9234</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="183" to="194" />
			<date type="published" when="2008">2008</date>
			<publisher>Royal Society of Chemistry (RSC)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Jakupec, M. A.; Galanski, M.; Arion, V. B.; Hartinger, C. G.; Keppler, B. K. Dalton Trans. 2008, 2, 183-194.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">&lt;mml:math xmlns:mml=&quot;http://www.w3.org/1998/Math/MathML&quot; display=&quot;inline&quot;&gt;&lt;mml:mi&gt;K&lt;/mml:mi&gt;&lt;/mml:math&gt;-edge absorption spectra of selected vanadium compounds</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Lytle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Messmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Maylotte</surname></persName>
		</author>
		<idno type="DOI">10.1103/physrevb.30.5596</idno>
	</analytic>
	<monogr>
		<title level="j">Physical Review B</title>
		<title level="j" type="abbrev">Phys. Rev. B</title>
		<idno type="ISSN">0163-1829</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="5596" to="5610" />
			<date type="published" when="1984-11-15">1984</date>
			<publisher>American Physical Society (APS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Wong, J.; Lytle, F. W.; Messmer, R. P.; Maylotte, D. H. Phys. Rev. B 1984, 30, 5596-5610.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">A New Method for Determination of the Edge Position of X-ray Absorption Spectra</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dittmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Iuzzolino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Dörner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-F</forename><surname>Nolting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Meyer-Klaucke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dau</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-94-011-3953-3_316</idno>
	</analytic>
	<monogr>
		<title level="m">Photosynthesis: Mechanisms and Effects</title>
		<imprint>
			<publisher>Springer Netherlands</publisher>
			<date type="published" when="1998">1998</date>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1339" to="1342" />
		</imprint>
	</monogr>
	<note type="raw_reference">Dittmer, J.; Iuzzolino, L.; Dörner, W.; Nolting, H.; Meyer-Klaucke, W.; Dau, H. In Photosynthesis: Mechanisms and Effects; Kluwer Academic Publishers: Dortrecht, 1998; Vol. 2, pp. 1339-1342.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
